. Anne-d-'andon, Tumeurs mésenchymateuses malignes ou sarcomes des parties molles, Institut Gustave-Roussy. Juin, pp.9-12, 2003.

G. Rhabdomyosarcome, |. Roussy, and . Centre-de-lutte-contre-le-cancer-en-europe, Disponible sur: https://www.gustaveroussy.fr/fr/content/rhabdomyosarcome 3. exe-plaquette-info-sarcomes-rhabdomyosarcomes.indd exe-plaquette-info-sarcomesrhabdomyosarcomes .pdf [Internet]. [cité 11 oct 2016]. Disponible sur: http://www.infosarcomes.org/sites

S. Malempati and D. Hawkins, Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies, Pediatric Blood & Cancer, vol.25, issue.1, pp.5-10, 2012.
DOI : 10.1200/JCO.2007.12.2473

O. Oberlin, A. Rey, E. Lyden, G. Bisogno, M. Stevens et al., Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups, Journal of Clinical Oncology, vol.26, issue.14, pp.2384-2393, 2008.
DOI : 10.1200/JCO.2007.14.7207

O. Oberlin, A. Rey, E. Lyden, G. Bisogno, M. Stevens et al., Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups, Journal of Clinical Oncology, vol.26, issue.14, pp.2384-2393, 2008.
DOI : 10.1200/JCO.2007.14.7207

S. Vignot, principaux protocoles de chimiothérapie en oncologie In: 2011 e éd. Groupe Hospitalier Pitié Salpetrière, p.228

L. Wagner, J. Perentesis, J. Reid, M. Ames, S. Safgren et al., Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study, Pediatric Blood & Cancer, vol.25, issue.4, pp.538-583, 2010.
DOI : 10.1002/pbc.22407

M. Moukhlissi, M. Aitidir, I. Bouamama, K. Maani, and J. Hachim, La prise en charge de la douleur chez l'enfant cancéreux, Disponible sur

C. Laboratoire-d-'hématologie-cellulaire-du, Disponible sur: http://hematocell.univ-angers.fr/index.php/enseignement-de-lhematologie-cellulaire/63- enseignement-de-lhematologie-cellulaire-les-principales-maladies-hematologiques/autres- situations-pathologiques-hematologie-generale/103-aplasies-medullaires, Angers [Internet], 2016.

C. O. Projet-education-thérapeutique-pôle-léonard-de-vinci, T 37 Réseau oncologie 37 et centre -présentation-du-projet-PEPS-37-Blois-2014.pdf [Internet]. [cité 14 oct 2016]. Disponible sur: http://oncocentre.org/wp-content/uploads/pr%C3%A9sentation-du-projet-PEPS-37-Blois- 2014

D. Williamson, E. Missiaglia, A. De-reynies, G. Pierron, B. Thuille et al., Fusion Gene???Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma, Journal of Clinical Oncology, vol.28, issue.13, p.2151, 2010.
DOI : 10.1200/JCO.2009.26.3814

S. Gallego, D. Toledo, J. , and R. J. , Molecular Genetics of Rhabdomyosarcoma Ltd, éditeur. eLS [Internet], Disponible sur, p.2012, 2016.
DOI : 10.1002/9780470015902.a0023883

M. Word and -. Do-1, doc -rhabdomyosarcome-genetiquediagnostic .pdf [Internet]. [cité 11 oct 2016] Disponible sur: http://curie.fr/sites/default/files/rhabdomyosarcome-genetique-diagnostic.pdf 33, <B>RMS 2005 localisé : </B></BR>Recommandations « RMS 2005 » pour les rhabdomyosarcomes localisés (à l'exception des RMS localisés de haut risque) avec étude du profil d'expression génomique des tumeurs [Internet]. [cité 2 nov 2016]. Disponible sur

S. Malempati and D. Hawkins, Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies, Pediatric Blood & Cancer, vol.25, issue.1, pp.5-10, 2012.
DOI : 10.1200/JCO.2007.12.2473

A. Bodmer, L. Goetsch, L. Favet, C. Bailly, N. Corvaia et al., Anticorps et tumeurs solides, m??decine/sciences, vol.25, issue.12, pp.1090-1098, 2009.
DOI : 10.1051/medsci/200925121090

D. Leroith, The insulin-like growth factor system and cancer, Cancer Letters, vol.195, issue.2, p.54, 1995.
DOI : 10.1016/S0304-3835(03)00159-9

E. Maloney, J. Mclaughlin, N. Dagdigian, L. Garrett, K. Connors et al., An Anti- Insulin-like Growth Factor I Receptor Antibody That Is a Potent Inhibitor of Cancer Cell Proliferation, Cancer Res. 15 août, vol.63, issue.16, pp.5073-83, 2003.